Cash Glut Meets Legal Storm: POET Technologies Struggles to Outrun Its Own Growth Story

POET holds $429M cash and plans to multiply manufacturing tenfold by 2027, but faces securities class actions and a 44% downside analyst consensus.

A company sitting on nearly half a billion dollars in cash, with plans to multiply manufacturing capacity tenfold by 2027, should be a market darling. Instead, POET Technologies finds itself fighting a twin threat: a wave of securities lawsuits and an analyst consensus that points to a 44% downside from current levels. The contradiction has investors scrambling to separate the growth narrative from the legal reality.

A $400 Million War Chest and a Tenfold Production Ambition

On May 18, POET completed a blockbuster capital raise, placing 19 million new shares alongside warrants with a single institutional investor for gross proceeds of $400 million. The move swelled the company’s liquidity position to over $429 million as of March 31 — enough, management says, to fund operations for roughly two and a half years.

The money is earmarked for a dramatic expansion of wafer fabrication capacity in Singapore and Malaysia, targeting a tenfold increase by 2027. The scale-up underpins POET’s “Optical Interposer” platform, which supplies optical connectivity solutions for AI data centers. The goal is to convert an existing $50 million order from partner Lumilens into recurring revenue and capture a slice of the booming AI infrastructure market.

Q1 Numbers Tell a Development-Stage Story

The expansion plans are ambitious, but the financials remain modest. In the first quarter of 2026, POET generated revenue of roughly $503,000 — a tiny figure for a company sporting a $2.55 billion market capitalization. The net loss came in at $12.3 million, or $0.08 per share, with operating cash burn running at about $8.8 million.

Those numbers reflect a business still in its pre-revenue growth phase. The market has been willing to look past the losses, driving the stock up more than 133% year-to-date at one point. But that rally has lost momentum as legal clouds gathered.

Multiple Class Actions Target CFO’s Alleged NDA Breach

On May 8, the law firm Kirby McInerney LLP filed a securities fraud class action on behalf of investors who purchased POET shares between April 1 and April 27, 2026. A second suit, filed by Pomerantz LLP, makes similar allegations. The lead plaintiff deadline for both actions is June 29.

The core of the complaint centers on an alleged breach of a nondisclosure agreement by chief financial officer Thomas Mika. In a public interview, he is accused of revealing confidential business arrangements — a misstep that, according to the lawsuits, led directly to the cancellation of orders from partners including Marvell Technology and its subsidiary Celestial AI. The stock suffered a sharp drop in late April as the news broke.

A second claim involves the company’s tax classification as a Passive Foreign Investment Company (PFIC), which the suits say was misrepresented to U.S. investors, potentially exposing them to adverse tax treatment. POET has announced plans to redomicile its legal headquarters to the United States to resolve the PFIC issue permanently.

Analyst Skepticism Runs Deep

The legal turmoil has reinforced a cautious stance on Wall Street. On May 21, 24/7 Wall St. slapped a “Sell” rating on POET shares with a price target of $10.38 — roughly 30% below the stock’s then-closing price of $14.78. The firm cited the disconnect between the year’s 133%-plus rally and the company’s actual earnings power, amplified by the litigation risk.

The broader analyst community is even more bearish. The median price target currently stands at $8.20, implying potential downside of about 44% from the May 21 close of $14.82. POET’s 52-week high of $20.81 and low of $3.87 highlight the stock’s extreme volatility.

Since reaching its May highs, the share price has already pulled back roughly 28%, trading in the mid-teens. For a company that has just filled its coffers and laid out an aggressive production timetable, the path ahead depends heavily on whether the CFO’s alleged NDA breach proves to be a one-off incident — or a sign of deeper control weaknesses that could scare off future partners.